✦ LIBER ✦

Costs of treatment and outcomes associated with second-line therapy and greater for relapsed ovarian cancer

✍ Scribed by Monica Prasad; Leah Ben-Porat; Brad Hoppe; Carol Aghajanian; Paul Sabbatini; Dennis S Chi; Martee L Hensley

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Second-line therapy of advanced ovarian

✍ G. Balbi; L. D. Piano; A. Cardone; G. Cirelli 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Second line treatment with VM 26, doxoru

📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Costs and Clinical Outcomes Associated w

✍ Charles E. Phelps; Erin K. Buysman; Gabriel Gomez Rey 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 485 KB

Thrombocytopenia associated with second-

✍ Maurie Markman; Jon Markman; Kenneth Webster; Kristine Zanotti; Barbara Kulp; Ge 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 164 KB

Association between pretreatment CA-125

✍ Maurie Markman; Bonnie Reichman; Thomas Hakes; John Curtin; Richard Barakat; Ste 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 387 KB

Computer modelling of diagnostic and tre

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 115 KB